title: Wave reflection predicts cardiovascular events in hypertensive individuals independent of blood pressure and other cardiovascular risk factors: an ASCOT (Anglo-Scandinavian Cardiac Outcome Trial) substudy.
abstract: OBJECTIVE
  This study investigated whether wave reflection measured by wave intensity analysis predicts future cardiovascular events in individuals with hypertension and sought to establish whether this relationship is independent of other cardiovascular risk factors and is associated with evidence of increased load on the left ventricle.
  
  
  BACKGROUND
  Wave reflection may impose an additional load on the left ventricle, and augmentation index, a surrogate of wave reflection, has been reported to predict cardiovascular events in some, but not all studies.
  
  
  METHODS
  Measurements of brachial and carotid blood pressure (BP) measurement, carotid ultrasound, echocardiography, and blood chemistry analyses were performed on 259 ASCOT (Anglo Scandinavian Cardiac Outcomes Trial) participants approximately 1 year after randomization, and wave intensity analysis was used to calculate wave reflection index (WRI), the ratio of peak forward to peak backward pressure (P(b)/P(f)), and carotid augmentation index (cAI(x)). All participants were followed up for a median period of 5.9 years, accruing 33 cardiovascular events.
  
  
  RESULTS
  WRI, P(b)/P(f), and to a lesser extent, cAI(x), were correlated. WRI predicted cardiovascular events (hazard ratio: 2.10; 95% confidence interval: 1.10 to 3.99; p = 0.02) in an unadjusted model. Multivariate analysis showed that this association was independent of BP. P(b)/P(f) and cAI(x) did not significantly predict cardiovascular events. WRI was also positively associated with increased left ventricular mass index and elevated B-type natriuretic peptide adjusted for age and sex, and these associations were independent of BP or other cardiovascular risk factors.
  
  
  CONCLUSIONS
  Higher wave reflection predicts future cardiovascular events independent of conventional risk factors in people with treated hypertension.
authors.affiliation: International Centre for Circulatory Health, Imperial College London & Imperial College Healthcare NHS Trust, London, United Kingdom.
authors.forename: Charlotte
authors.initials: C
authors.lastname: Manisty
authors.forename: Jamil
authors.initials: J
authors.lastname: Mayet
authors.forename: Robyn J
authors.initials: RJ
authors.lastname: Tapp
authors.forename: Kim H
authors.initials: KH
authors.lastname: Parker
authors.forename: Peter
authors.initials: P
authors.lastname: Sever
authors.forename: Neil R
authors.initials: NR
authors.lastname: Poulter
authors.forename: Neil H
authors.initials: NH
authors.lastname: Poulter
authors.forename: Simon A McG
authors.initials: SA
authors.lastname: Thom
authors.forename: Alun D
authors.initials: AD
authors.lastname: Hughes
mesh_terms: D000368:Aged; D001794:Blood Pressure / Q000502:physiology*; D002318:Cardiovascular Diseases / Q000209:etiology*; D005260:Female; D006352:Heart Ventricles / Q000503:physiopathology; D006801:Humans; D006973:Hypertension / Q000150:complications* / Q000503:physiopathology; D008297:Male; D020097:Natriuretic Peptide, Brain / Q000097:blood; D012307:Risk Factors
chemical_list: D020097:Natriuretic Peptide, Brain